QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology 期刊论文 CANCER BIOLOGY & MEDICINE, 2019, 卷号: 16, 期号: 1 作者:  Wu, Chunyan;  Shao, Zhimin;  Xu, Binghe;  Zhang, Qingyuan;  Xu, Ruihua 收藏  |  浏览/下载：123/0  |  提交时间：2019/12/05 Next-generation sequencing technology  cancer  consensus   Cystathionine-gamma-lyase ameliorates the histone demethylase JMJD3-mediated autoimmune response in rheumatoid arthritis 期刊论文 CELLULAR & MOLECULAR IMMUNOLOGY, 2019, 卷号: 16, 期号: 8 作者:  Wu, Weijun;  Qin, Ming;  Jia, Wanwan;  Huang, Zheng;  Li, Zhongzheng 收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05 cystathionine-gamma-lyase  rheumatoid arthritis  Jumonji domain-containing protein 3  Sp-1  Toll like receptor 2   Cystathionine-gamma-lyase ameliorates the histone demethylase JMJD3-mediated autoimmune response in rheumatoid arthritis 期刊论文 CELLULAR & MOLECULAR IMMUNOLOGY, 2019, 卷号: 16, 期号: 8 作者:  Wu, Weijun;  Qin, Ming;  Jia, Wanwan;  Huang, Zheng;  Li, Zhongzheng 收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05 cystathionine-gamma-lyase  rheumatoid arthritis  Jumonji domain-containing protein 3  Sp-1  Toll like receptor 2   Methylation in the TP53 promoter is associated with ischemic stroke 期刊论文 MOLECULAR MEDICINE REPORTS, 2019, 卷号: 20, 期号: 2, 页码: 1404-1410 作者:  Wei, Yan;  Sun, Zhongzheng;  Wang, Yun;  Xie, Zhaohong;  Xu, Shunliang 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/11 tumor protein p53  methylation  ischemic stroke  epigenetics   Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology 期刊论文 2019, 卷号: 16, 期号: 1, 页码: 189-204 作者:  Zhang Xuchao;  Liang Zhiyong;  Wang Shengyue;  Lu Shun;  Song Yong 收藏  |  浏览/下载：26/0  |  提交时间：2020/01/03 Next-generation sequencing technology  cancer  consensus